UDG.L Regulatory News (UDG)

UDG HEALTHCARE PLC

 ("UDG Healthcare" or the "Company")

CFO Appointment

19 December 2017: UDG Healthcare, a leading international healthcare services provider, is pleased to announce the appointment of Nigel Clerkin as Chief Financial Officer of the Company. Nigel will start with the Company on 1 May 2018 and will replace Alan Ralph from that date. Alan will support the transition until his previously announced retirement in November 2018.

Nigel most recently held the position of Chief Financial Officer with ConvaTec Group plc, a London Stock Exchange listed company, where he worked for the last three years. ConvaTec is a global medical products and technologies company, employing approximately 9,000 employees worldwide. Prior to this, Nigel held roles in Elan Corporation plc, most recently as Executive Vice President and Chief Financial Officer, culminating in its sale to Perrigo Company plc in 2013. He started his career as an auditor with KPMG and is a qualified Chartered Accountant.

As Chief Financial Officer, the finance and the investor relations functions of UDG Healthcare will report into Nigel. Nigel will also be appointed a Director of the Company in May 2018.

Brendan McAtamney, UDG Healthcare's Chief Executive Officer, commented:

"We are delighted to welcome Nigel to UDG Healthcare. Nigel brings with him significant industry experience and an excellent track record of leading finance functions in the international healthcare sector. As we focus on our strategy, capitalising on the increasing trend within healthcare to outsource non-core and specialist activities, Nigel's appointment reinforces our commitment to attracting talent with relevant sectoral and operational experience that will help us implement that strategy. Together with the board and the wider executive team, I am very much looking forward to working with Nigel."

Nigel Clerkin commented:

"I am very happy to be joining UDG Healthcare at such an exciting time. Over the past number of years, UDG Healthcare has been transforming and growing into market leader positions within its key geographies. I look forward to building on this strong platform and helping Brendan and the team drive further international expansion across the Group."

There is no further information in relation to Nigel Clerkin's current or prior directorships that requires notification for the purpose of Listing Rule 9.6.13.

About UDG Healthcare plc

UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, commercial, clinical, communications and packaging services to the healthcare industry, employing over 9,000 people with operations in 24 countries and delivering services in over 50 countries.

UDG Healthcare plc operates across three divisions: Ashfield, Sharp and Aquilant.

Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry, operating across three broad areas of activity: advisory, communications and commercial & clinical services. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.

Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, operating from state-of-the-art facilities in the US and Europe.

Aquilant is a leading provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.

For more information, please go to: www.udghealthcare.com